Lifetime cost-effectiveness simulation of once-weekly exenatide in type 2 diabetes: A cost-utility analysis based on the EXSCEL trial

Autor: Becker, Frauke, Dakin, Helen A., Reed, Shelby D., Li, Yanhong, Leal, José, Gustavson, Stephanie M., Wittbrodt, Eric, Hernandez, Adrian F., Gray, Alastair M., Holman, Rury R.
Zdroj: In Diabetes Research and Clinical Practice January 2022 183
Databáze: ScienceDirect